Financial News
Latest News about JAZZ
Recent news which mentions JAZZ
Jazz Pharmaceuticals Explores Asset Sale Option, Possibly Cannabinoid Business: Report
October 20, 2023
Tickers
JAZZ
From Benzinga
I missed Beyoncé’s European tour, so I flew 4,600 miles to New Orleans to see her in concert — by myself
October 11, 2023
Tickers
JAZZ
From CNBC.com News
2 Top Biotech Stocks to Buy in October
October 03, 2023
From Motley Fool
5 Genius Safe Stocks to Buy for the 4th Quarter of 2023
October 02, 2023
From Motley Fool
4 Perfect Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
September 30, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
From Benzinga
3 Cannabis Stocks That Should Be on Every Investor’s Radar This Fall
September 27, 2023
From InvestorPlace
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall
September 20, 2023
From InvestorPlace
7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom
September 19, 2023
From InvestorPlace
Cannabis Industry Changes As Marijuana Rescheduling Looms
September 15, 2023
From Benzinga
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
From Benzinga
10 growth stocks that are trading at bargain prices, including Delta and Cheniere Energy
August 30, 2023
From MarketWatch
From Motley Fool
Jazz Pharmaceuticals' Neuroscience Pipeline Readouts In Focus: Analyst Lowers Price Target
August 14, 2023
Tickers
JAZZ
From Benzinga
Cannabis Stock Gainers And Losers From August 11, 2023
August 11, 2023
From Benzinga
Jazz Pharmaceuticals Reports Q2 2023 Net Income Of $104.4M, What About Total Revenues?
August 09, 2023
Tickers
JAZZ
From Benzinga
3 Biotech Stocks You’ll Regret Not Buying Soon
August 08, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 08, 2023
From Benzinga
GOP Rep. Blasts FDA Over CBD Inaction During Historic Hearing: The Agency Wants More Money To Do Its Job
July 28, 2023
From Benzinga
FDA, Get It Done! Says Senator In Bipartisan Push To Regulate CBD Products Prior To Committee Hearing
July 21, 2023
From Benzinga
Divided GOP Helps This State Dodge Bullet From The Pot Lobby, Says Anti-Marijuana Group
July 10, 2023
From Benzinga
4 Unequaled Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
July 08, 2023
From Motley Fool
From Benzinga
Is Axsome Therapeutics Stock a Screaming Buy?
June 15, 2023
From Motley Fool
Stocks That Hit 52-Week Lows On Tuesday
June 13, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
